You are currently viewing European Pharmacovigilance Congress For Year 2024: The Key Takeaways and PVpharm’s Participation

European Pharmacovigilance Congress For Year 2024: The Key Takeaways and PVpharm’s Participation

  • Post published:November 28, 2024

The European Pharmacovigilance (EUPV) Congress 2024, held both virtually and in-person in Milan, Italy, once again demonstrated why it is a premier event for pharmacovigilance professionals worldwide. Organized by the Pharma Education Center, the congress brought together leading minds to explore emerging trends, share scientific advancements, and discuss strategies to enhance drug safety practices globally. PVpharm was honored to attend this prestigious event, connecting with industry leaders and participating in discussions shaping the future of pharmacovigilance.

European Pharmacovigilance Congress 2024

Key Highlights from the Conference

  • Diverse and Cutting-Edge Sessions
    The virtual sessions on November 18–19 covered critical topics, including the biological basis of adverse reactions, signal detection, and safety communication in the digital age. Discussions around risk management, safety in clinical trials, and non-EU pharmacovigilance requirements provided valuable global perspectives.
    The face-to-face sessions in Milan on November 22 emphasized practical applications, such as leveraging artificial intelligence in PV, managing global and local PV updates, and conducting effective audits and inspections. Workshops further deepened participants’ understanding of real-world challenges and solutions in pharmacovigilance.
  • Global and Local Regulatory Insights
    The congress highlighted the evolving regulatory landscape, including current QPPV requirements in Saudi Arabia and updates on MedDRA. These sessions underscored the importance of staying informed about international guidelines to maintain compliance and ensure patient safety.

PVpharm’s Contribution to the Event

PVpharm presented two poster presentations, one of them received the first prize of the category

Attending the EUPV Congress provided PVpharm with invaluable opportunities to engage with key decision-makers, explore cutting-edge pharmacovigilance practices, and strengthen its commitment to delivering exceptional PV services. The event also served as a platform to connect with partners and peers, fostering collaboration and knowledge exchange in the ever-evolving world of pharmacovigilance.

We look forward to implementing the insights gained at the EUPV Congress and continuing our mission to support safer medicines worldwide. Thank you to all the organizers, speakers, and attendees for making this year’s event a resounding success!

For more updates on our activities and insights, follow PVpharm’s blog and social media channels.

Check this: PVpharm: Solving the Riddle of Pharmacovigilance Compliance.